Covington Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Covington Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29	Closed	-$2K	–	1214
2022 Q1	$2K	Buy	+29	New	+$1.54K	﹤0.01%	1049
2021 Q4	–	Sell	-100	Closed	-$6K	–	1076
2021 Q3	$6K	Sell	100 -300	-75%	-$18.5K	﹤0.01%	884
2021 Q2	$27K	Buy	+400	New	+$27.3K	﹤0.01%	636

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Covington Capital Management's NUVA Position: Q2 2022 in Review

Covington Capital Management sold out of NuVasive, Inc. (NUVA) in Q2 2022, closing a stake of 29 shares — an estimated $2K sold.

Covington Capital Management first reported a position in NUVA in Q2 2021 and held it in 3 quarters. The position peaked at $27K in Q2 2021. 237 funds tracked by Wall St. Rank hold NUVA as of Q2 2022.

Covington Capital Management reported no remaining NuVasive, Inc. position as of Q2 2022 after selling out during the quarter.
Covington Capital Management sold 29 NuVasive, Inc. shares in Q2 2022, an estimated $2K.
Covington Capital Management first reported a position in NuVasive, Inc. in Q2 2021 and held it in 3 quarters.
Covington Capital Management's NuVasive, Inc. position peaked at $27K in Q2 2021.
237 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2022.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.